Supplementary Files
Keywords
How to Cite
Abstract
Objective: To compare the effects of a combination of Myo-inositol and Metformin versus Metformin alone on hirsutism and acne in PCOS patients.
Methods: A total of 114 adult PCOS patients with hirsutism as well as acne underwent an 8-months randomization (September 2022 to May 2023) at Khyber Teaching hospital Peshawar outpatient department of gynecology and obstetrics, to one of the two treatments (double blinded study), where Group A included of 57 individuals taking combination of 500 mg of oral Metformin three times each day and Myo-inositol 4000 mg once daily; Group B included 57 individuals taking 500 mg of oral Metformin three times each day as single therapy. All hormonal, metabolic, and clinical indicators were assessed at the initial and eight-month points after the commencement of medication.
Results: A Significant difference was noted in terms of mean change in Farriman-Gallwey score in Group A (n=55), 3.59±0.81, versus Group B (n=54), 4.68±0.55 (p=0.00). Similarly, there was a notable improvement in mean change in Global acne score in Group A 1.51±0.50 when compared to Group B 2.38±0.67 (p =0.00), similarly there was significant differences between Group A 33.2±3.01 and Group B 41.5±32.99 in terms of mean serum Total testosterone levels p=0.00 and significant difference between Group A 95.56±5.71 and Group B 146.70±15.75 in terms of mean serum DHEA levels p=0.00.
Conclusion: By balancing hormones and improving metabolic profile, Myo-inositol and Metformin, when used in combination, are more successful in treating hirsutism and acne in adult PCOS patients as compared to metformin alone.
Keywords: Polycystic ovarian syndrome, hirsutism, myo-inositol, metformin
References
Siddiqui S, Mateen S, Ahmad R, Moin S. A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS). J Assist Reprod Genet. 2022 Nov 1;39(11):2439–73. https://doi.org/10.1007/s10815-022-02625-7
Guo Z, Jin F, Chen S, Hu P, Hao Y, Yu Q. Correlation between biochemical and clinical hyperandrogenism parameter in polycystic ovary syndrome in relation to age. BMC Endocrine Disorders. 2023;23(1):1-9 https//doi.org/10.1186/s12902-023-01346-x
El-Sheshtawy RA, Elsamie A, Elsamie AA, Bosilah AH, Gomaa MM, El RA. Correlation of Metabolic Syndrome in Different Phenotypes of Polycystic Ovary Syndrome and Pregnancy Rate. Fayoum University Medical Journal. 2022, 10(3), 11-18; Available from: https://fumj.journals.ekb.eg/
Mishra AJ, Sharma S. I have lost my Identity: Disease Management Challenges of the Women Suffering from Polycystic Ovary Syndrome (PCOS). Journal of Health Management. 2022 July;24(4):608–16. https://doi.org/10.1177/09720634221112136
Artar G, Tas B, Turan G, Uckan HH. Evaluation of androgen-dependent skin findings of polycystic ovary syndrome (PCOS). Gynecological Endocrinology. 2022;38(12):1104–8. https://doi.org/10.1080/09513590.2022.2162496
Genazzani AD, Battipaglia C, Semprini E, Arnesano M, Ambrosetti F, Sponzilli A, et al. Familial Diabetes in Obese PCOS Predisposes Individuals to Compensatory Hyperinsulinemia and Insulin Resistance (IR) Also for Reduced Hepatic Insulin Extraction (HIE). Journal Endocrines 2022;3(2):296–302; https://doi.org/10.3390/endocrines3020024
Bizuneh AD, Joham AE, Tay CT, Kiconco S, Earnest A, Dhungana RR, et al. The PCOS Phenotype in Unselected Populations study: ethnic variation in population-based normative cut-offs for defining hirsutism. European Journal of Endocrinology. 2025 Mar 1;192(3):228–39. https://doi.org/10.1093/ejendo/lvaf030
Witkam WCAM, Dal Belo SE, Pourhamidi S, Raynaud E, Moreau M, Aguilar L, et al. The epidemiology of acne vulgaris in a multiethnic adolescent population from Rotterdam, the Netherlands: A cross-sectional study. Journal of the American Academy of Dermatology. 2024 Mar 1;90(3):552–60. https://doi.org/10.1016/j.jaad.2023.10.062
Özkesici Kurt B. Acne in Adolescents and Self-Esteem. Handbook of the Behavior and Psychology of Disease. 2024;1–11. Springer, Cham. https://doi.org/10.1007/978-3-031-32046-0_18-1
Kelly FA, de Oliveira Macena Lôbo A, Cardoso JHCO, de Moraes FCA. Comparison of metformin with inositol versus metformin alone in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Journal of the Endorine Society. 2024 Sep 27;87(2):389–99. https//doi.org/10.1007/s12020-024-04052-3
Yasir S. Eihassan, James M. Hawley, Leanne Cussen, Ali Abbara, Soophie A. Clarke, Punith Kempegowda, et al. Society for endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women. Clinical endocrinology. 2025 May;103(4):540-566. https://doi.org/10.1111/cen.15265
Masood S, Hashmani SR. Pharmacologic management for polycystic ovary syndrome: Hirsutism and acne. Polycystic Ovary Syndrome: Basic Science to Clinical Advances across the Lifespan. 2024 Jan 1;117–21. https://doi.org/10.1016/B978-0-323-87932-3.00024-4
Matossian GA, Buklarewicz IM, Moosa VA. The Effects of Metformin and Myo-Inositol on Hyperandrogenism, Insulin Sensitivity, and Fertility in Polycystic Ovary Syndrome: A Literature Review. Undergraduate Research in Natural and Clinical Science and Technology Journal. 2023 Sep;7(1):1–10. https://doi.org/10.26685/urncst.483
Sherin Attia Shazly, Amal Ahmed Zidan, Doaa Abdallah Abdelrahman Gomma, Hoda Sibai Abd Alsalam. Effect of Short Period Administration of Inositol and Metformin on Hormonal and Lipid Profile in Women with Polycystic Ovary Syndrome. Zagazig University Medical Journal. 2025 July;31(7):2884–94. https//doi.org/10.21608/zumj.2025.364005.3857
Agrawal A, Mahey R, Kachhawa G, Khadgawat R, Vanamail P, Kriplani A. Comparison of metformin plus myoinositol vs metformin alone in PCOS women undergoing ovulation induction cycles: randomized controlled trial. Gynecological Endocrinology. 2019 June 3;35(6):511–14. https://doi.org/10.1080/09513590.2018.1549656
Karadağ C, Sakinci M, Birge Ö, Bakır MS, Karadağ B, Sağnıç S. Comparison of metformin, myoinositol and metformin-myoinositol combined treatments for polycystic ovary syndrome. Turk J Obstet Gynecol. 2024 Jun 10;21(2):78–84. https//doi.org/ 10.4274/tjod.galenos.2024.21456
Nagaria G. Effect of Myoinositol and Metformin in combination on clinical and hormonal profile in patients of polycystic ovarian syndrome. Int J Reprod Contracept Obstet Gynecol. 2019;8(2):702–9. DOI: https://doi.org/10.18203/2320-1770.ijrcog20190309
Fruzzetti F, Perini D, Russo M, Bucci F, Gadducci A. Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS). Gynecological Endocrinology. 2017 Jan 2;33(1):39–42. https://doi.org/10.1080/09513590.2016.1236078
Reader SM, Duraisingam A. Comparative study on the use of myoinositol and metformin in the improvement of clinical symptoms and biochemical parameters in women with polycystic ovarian syndrome. International Journal of Clinical Obstetrics and Gynaecology. 2020;4(6): 87–92. https://doi.org/10.33545/gynae.2020.v4.i6b.737
Wazir S, Rahman F, Bibi R, Hassan T, Farooqi K, Afridi N. Comparison of the Effectiveness and Safety of Myo Inositol with Metformin for the Treatment of Polycystic Ovary Syndrome in Women. Pakistan Journal of Medical and Health Sciences. 2022 Aug 31;16(8):926–28. https://doi.org/10.53350/pjmhs22168926
Le NSV, Le MT, Cao TN. Myo-inositol versus metformin effects on clinical features, endocrine and metabolic profiles in infertile women with polycystic ovary syndrome: A randomized controlled trial. Asian Pacific Journal of Reproduction. 2023 December;12(6):256–65. https//doi.org/10.4103/2305-0500.390300
Bahadur A, Arora H, Ravi AK, Naithani M, Bahurupi Y, Chaturvedi J, et al. Comparison of Clinical, Metabolic and Hormonal Effects of Metformin Versus Combined Therapy of Metformin With Myoinositol Plus D-Chiro-Inositol in Women With Polycystic Ovary Syndrome (PCOS): A Randomized Controlled Trial. Cureus U Endocrinology. 2021 Jun 8;13(6):1–7. https//doi.org/10.7759/cureus.15510
Thakur SS, Anjum S, Siddiqui SS. Randomised controlled trial: comparing effects of metformin versus myoinositol versus metformin and myoinositol on ovarian functions and metabolic factors in polycystic ovarian syndrome. Int J Reprod Contracept Obstet Gynecol. 2020 June 27;9(6):2542–49. https://doi.org/10.18203/2320-1770.ijrcog20202345
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyright (c) 2026 Hira Ehsan Khattak, Syeda Khadija Mahrukh, Atif Ullah, Muhammad Zahid, Sadia Gul, Ayesha Khan